Skip to main content
Marike R. Wevers on Muck Rack

Marike R. Wevers

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Marike R.

Contact Marike R., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers - Communications Biology

|
By John Pearson, Joe Dennis, Daniel Barnes Verified, Peter D. Mace, Irene L. Andrulis, Jacopo Azzollini, Marinus J. Blok, Joan Brunet, Ian Campbell, Wendy Chung, GEMO Study Collaborators, EMBRACE Collaborators, Sita Dandiker, Robin de Putter, Douglas F. Easton, Hans Ehrencrona, Lidia Feliubadaló, Simon A. Gayther, Paul Gesta, Andrew Godwin, Mark Greene, Jan Hauke, Peter J Hulick, SWE-BRCA Investigators, K ConFab Investigators, HEBON Investigators, Claudine Isaacs, Louise Izatt, Ángel Cabrera Izquierdo, Anna Jakubowska, Paul James, Vijai Joseph, Beth Karlan, Irene Konstantopoulou, Conxi Lázaro, Goska Leslie, Fabienne El-Khoury Lesueur, Austin L. Miller Verified, Sophie Nambot, Katherine L. Nathanson, Susan Neuhausen, Heli Nevanlinna, Liene Nikitina-Zake, Olufunmilayo I. Olopade, Ana Osorio, Claus-Eric Ott, Sue K Park, Michael Parsons, Inge Sokilde Pedersen, Paolo Peterlongo, Paolo Radice, Efraim H Rosenberg, Jacques Simard, Doris Steinemann, Christian Sutter, Manuel R. Teixeira, Soo Hwang Teo, Marc Tischkowitz, Amanda E. Toland, Vishakha Tripathi, Ana Francisca Vega Verified, Alessandra Viel, Jeffrey N. Weitzel, Marike R. Wevers, Amanda B. Spurdle
| Nature Verified
Study cohort Female BRCA1 and BRCA2 pathogenic variant carriers were from study centres across North America, Europe, and Australia participating in CIMBA (Supplementary Data 12), as reported previously4,5. Eligibility criteria for study participants included: (1) female carriers of BRCA1 or BRCA2 pathogenic variants; and (2) minimum 18 years of age at recruitment.
Open in Who Shared Issue with article?
See all 1 articles